Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

BioMimetic Therapeutics, Inc. announced that the Company has approved a seven-day extension of the Company's pending subscription rights offering on June 2009, unless further extended by the Company. Pursuant to the subscription rights offering, each holder of record of the Company's common stock as of April 2009 received one non-transferable subscription right for each share of common stock owned by such holder on such date, except with respect to shares of common stock held by the BioMimetic 401K Plan.


   

Today in Popular Press...keeping you current

Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products
Boehringer Ingelheim, 10/30/09

NIH has awarded $75 million for disparities research
American Hospital Association News, 11/16/09

Medical schools continue to enroll more students, AAMC reports
American Hospital Association News, 11/13/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address